A rare case of chronic myelogenous leukemia and plasma cell myeloma in the same patient.
作者信息
Ahn Sunhyun, Park Joon Seong, Han Jae Ho, Cho Sung Ran
机构信息
Department of Laboratory Medicine, Ajou University School of Medicine, Suwon, Korea.
Department of Internal Medicine, Ajou University School of Medicine, Suwon, Korea.
出版信息
Ann Lab Med. 2015 May;35(3):370-2. doi: 10.3343/alm.2015.35.3.370. Epub 2015 Apr 1.
Abstract
摘要
相似文献
1
A rare case of chronic myelogenous leukemia and plasma cell myeloma in the same patient.
Ann Lab Med. 2015 May;35(3):370-2. doi: 10.3343/alm.2015.35.3.370. Epub 2015 Apr 1.
2
Chronic myelogenous leukemia evolving after treatment of multiple myeloma.
Blood. 2016 Jul 7;128(1):146. doi: 10.1182/blood-2016-03-706945.
3
Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by imatinib in chronic myeloid leukemia.
Leuk Lymphoma. 2017 Feb;58(2):473-474. doi: 10.1080/10428194.2016.1201575. Epub 2016 Jul 7.
4
Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status.
Am J Clin Pathol. 2003 Jun;119(6):833-41. doi: 10.1309/A4RG-P4LF-12GG-H8MW.
5
Isolated polyglobulia as an uncommon presentation of chronic myeloid leukaemia.
Blood Cells Mol Dis. 2016 Jan;56(1):37. doi: 10.1016/j.bcmd.2015.10.008. Epub 2015 Oct 28.
6
[Diagnosis and treatment of chronic myelogenous leukemia].
Rev Prat. 2005 Oct 15;55(15):1647-57.
7
A case report of chronic myelogenous leukemia in a patient with multiple myeloma and a review of the literature.
Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):175-9. doi: 10.1016/j.clml.2012.09.010. Epub 2012 Nov 15.
8
Multiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia.
Ann Hematol. 2009 Mar;88(3):281-2. doi: 10.1007/s00277-008-0597-2. Epub 2008 Aug 26.
9
[Chronic myelogenous leukemia with marked thrombocytosis].
Rinsho Ketsueki. 2001 Mar;42(3):199-203.
10
Promyelocytic Blastic Crisis in Chronic Myeloid Leukemia During Imatinib Treatment.
Turk J Haematol. 2015 Jun;32(2):193-4. doi: 10.4274/tjh.2014.0211.
引用本文的文献
1
Prostate cancer, chronic myelogenous leukemia and multiple myeloma in a single patient: a case report and review of the literature.
J Med Case Rep. 2023 Feb 5;17(1):35. doi: 10.1186/s13256-023-03753-z.
2
An Unprecedented Case of p190 Chronic Myeloid Leukemia Diagnosed during Treatment for Multiple Myeloma: A Case Report and Review of the Literature.
Case Rep Hematol. 2018 Oct 10;2018:7863943. doi: 10.1155/2018/7863943. eCollection 2018.
本文引用的文献
1
[The combination of chronic myeloid leukemia and multiple myeloma in one patient].
Vopr Onkol. 2013;59(2):103-10.
2
Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies.
Blood. 2011 Oct 20;118(16):4353-8. doi: 10.1182/blood-2011-06-362889. Epub 2011 Aug 16.
3
Uncommon case of chronic myeloid leukemia with multiple myeloma.
Int J Hematol. 2010 May;91(4):699-704. doi: 10.1007/s12185-010-0546-4. Epub 2010 Mar 30.
4
Chronic myeloid leukaemia.
Lancet. 2007 Jul 28;370(9584):342-50. doi: 10.1016/S0140-6736(07)61165-9.
5
Epidemiological analysis of second primary malignancies in more than 9500 patients treated with imatinib.
Leukemia. 2006 Jan;20(1):148; author reply 149. doi: 10.1038/sj.leu.2404025.
6
Imatinib mesylate (STI571) inhibits multiple myeloma cell proliferation and potentiates the effect of common antimyeloma agents.
Br J Haematol. 2003 Dec;123(5):858-68. doi: 10.1046/j.1365-2141.2003.04706.x.
7
Simultaneous occurrence of multiple myeloma and chronic myeloid leukemia.
Haematologica. 2001 Aug;86(8):894.
8
Is the primary event in radiation-induced chronic myelogenous leukemia the induction of the t(9;22) translocation?
Leuk Res. 1992;16(4):333-6. doi: 10.1016/0145-2126(92)90134-s.
Zotero 插件